CardioHeartConnect Mobile Cardiac Rehabilitation Using Peloton for Patients Recovering From Transcatheter Aortic Valve Replacement

What this Trial Is About

Researchers are evaluating CardioHeartConnect, an eight-week mobile cardiac rehabilitation program using Peloton fitness modules, compared to educational materials among patients recovering from transcatheter aortic valve replacement TAVR. The study aims to improve physical activity, functional capacity, quality of life, and cardiovascular health in this population. It addresses low participation rates in cardiac rehabilitation, especially among patients with other health issues, underserved groups, and those in rural areas. Participants are randomly assigned to either the CardioHeartConnect group, which completes daily Peloton exercise modules focused on low-impact activities like walking, stretching, yoga, and strength training, or to the CardioHeartEd group, which receives weekly educational materials from the American College of Cardiology. Both groups receive a smartwatch and access to the Ortus-iHealth platform for data collection and engagement. The program is home-based and digitally delivered over eight weeks. Participants are assessed at the start, after 8 weeks, and at 12 months. Assessments include surveys, smartwatch activity tracking, and electronic health record reviews. Researchers measure changes in physical activity, functional capacity, cardiovascular health, quality of life, self-efficacy, and healthcare use. The study also monitors safety events and evaluates implementation outcomes. Total follow-up lasts 12 months after randomization, allowing long-term observation of effects and participation.

CardioHeartConnect: Commercially Available Fitness for Cardiac Rehabilitation